These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10551485)

  • 1. Bone metastases from poorly differentiated adenocarcinoma of the prostate diagnosed by In-111 ProstaScint (Capromab Pendetide) images with negative results of Tc-99m MDP bone scan and without significant elevation of prostate-specific antigen.
    Norris S; Halkar R; Galt J; Petros J; Keller J
    Clin Nucl Med; 1999 Nov; 24(11):905-7. PubMed ID: 10551485
    [No Abstract]   [Full Text] [Related]  

  • 2. [Visualisation of prostate cancer liver metastases on a 99mTc-MDP bone scan].
    Loaiza Góngora JL; Hervás Benito I; Bello Arques P; Vercher Conejero JL; Mateo Navarro A
    Rev Esp Med Nucl; 2009; 28(2):80. PubMed ID: 19406055
    [No Abstract]   [Full Text] [Related]  

  • 3. Capromab Pendetide imaging of prostate cancer.
    Haseman MK; Rosenthal SA; Polascik TJ
    Cancer Biother Radiopharm; 2000 Apr; 15(2):131-40. PubMed ID: 10803318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
    Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase.
    Yuksel M; Cermik TF; Kaya M; Salan A; Ustun F; Salihoglu YS; Yigitbasi ON; Berkarda S
    Clin Nucl Med; 2001 Nov; 26(11):962. PubMed ID: 11595863
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate.
    Bruwer G; Heyns CF; Allen FJ
    Eur Urol; 1999; 35(3):223-7. PubMed ID: 10072624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraoperative scintigraphic visualization of a single rib metastasis from operated prostatic adenocarcinoma].
    Sanjurjo S; Hamida W; Letesson G; Hustinx R; Gillet P; Andrianne R
    Prog Urol; 2008 Jun; 18(6):402-5. PubMed ID: 18558331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible false-positive metastatic prostate cancer on an In-111 capromab pendetide scan as a result of a pelvic kidney.
    Valliappan S; Joyce JM; Myers DT
    Clin Nucl Med; 1999 Dec; 24(12):984-5. PubMed ID: 10595486
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Super bone scan: bone metastases of prostate cancer.
    Shikino K; Ikusaka M; Hirota Y; Sato E
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25228679
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioimmunoguided surgery using indium-111 capromab pendetide (PROSTASCINT) to diagnose supraclavicular metastasis from prostate cancer.
    Anderson RS; Eifert B; Tartt S; King P
    Urology; 2000 Oct; 56(4):669. PubMed ID: 11018634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sub-super bone scan caused by bone marrow involvement of prostate cancer.
    Seo Y; Shuke N; Yamamoto W; Usui K; Aburano T
    Ann Nucl Med; 1999 Oct; 13(5):351-4. PubMed ID: 10582806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure.
    Ellis RJ; Zhou EH; Fu P; Kaminsky DA; Sodee DB; Faulhaber PF; Bodner D; Resnick MI
    J Urol; 2008 May; 179(5):1768-73; discussion 1773-4. PubMed ID: 18343445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Solitary hypermetabolic bone focus in the initial extension study of a prostate carcinoma].
    Sampol Bas C; Peña Viloria C; Giménez García M
    Rev Esp Med Nucl; 2005; 24(6):414-7. PubMed ID: 16324519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report: accumulation of 99mTc-hydroxymethylene diphosphonate by liver metastases of prostatic adenocarcinoma.
    Mannion RA; Johnson M
    Clin Radiol; 1993 Mar; 47(3):209-10. PubMed ID: 8472488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer abdominal metastases detected with indium-111 capromab pendetide.
    Hinkle GH; Burgers JK; Olsen JO; Williams BS; Lamatrice RA; Barth RF; Rogers B; Maguire RT
    J Nucl Med; 1998 Apr; 39(4):650-2. PubMed ID: 9544673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer.
    Queiroz MA; Viana P; Santos A; Bastos D; Etchebehere E; Cerri G
    Clin Nucl Med; 2016 Sep; 41(9):e417-9. PubMed ID: 27276202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraindividual Comparison of
    Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
    J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indium-111 capromab pendetide in the management of recurrent prostate cancer.
    Manyak MJ
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):175-81. PubMed ID: 18279057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy between clinical symptoms and Tc-99m MDP bone scan findings before and after strontium-89 therapy for metastatic bone pain of prostate carcinoma.
    Sun SS; Tsai SC; Hsieh JF; Lee JK; Kao CH
    Clin Nucl Med; 2001 Feb; 26(2):167-9. PubMed ID: 11201488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.